Infectious Disease Diagnostics – News and Features

Composite polymer particles adorned with gold nanoparticles could improve the accuracy of infectious disease testing, reports a new study.

Scientists have developed a novel blood test to measure the immune response to the Epstein-Barr virus, the leading risk factor for developing multiple sclerosis. The test has the potential to be applied in clinical trials that target the virus.

A team of researchers at Tohoku University has reported on a high-performance magnesium-air (Mg-air) battery that is paper-based and activated by water.

Scientists have taken a major step towards developing a blood test that could identify millions of people who spread tuberculosis unknowingly.

CRISPR-based test detects a genetic target that is specific to Burkholderia pseudomallei, the bacterium that causes melioidosis, with 93% sensitivity.

MIT chemists have designed a sensor that detects tiny quantities of perfluoroalkyl and polyfluoroalkyl substances (PFAS) — chemicals found in food packaging, nonstick cookware, and many other consumer products.

Leptospirosis is a globally distributed infectious disease that affects both animals and humans. The serological diagnostic test performs better when local variants are used.

A new analysis method can detect pathogens in blood samples faster and more accurately than blood cultures, which are the current state of the art for infection diagnosis.

A paper-based platform developed by researchers at the Indian Institute of Science (IISc) and Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) could help quickly detect the presence of antibiotic-resistant, disease-causing bacteria.

A new study has validated the use of a new system that can detect any virus that could potentially infect humans, bringing it one step closer to use in viral surveillance and diagnosis.